Format

Send to

Choose Destination
See comment in PubMed Commons below
Crit Care Med. 1998 Jan;26(1):40-3.

Intravenous administration of oral N-acetylcysteine.

Author information

1
Rocky Mountain Poison and Drug Center and Denver Health Medical Center, Department of Surgery, University of Colorado Health Science Center 80220, USA.

Abstract

OBJECTIVE:

To report the indications and adverse events associated with administration of the oral N-acetylcysteine preparation by the intravenous route.

DESIGN:

Retrospective consecutive case series analysis of 226,720 Toxic Exposure Surveillance System data sheets from a certified regional poison center during the period January 1, 1992 through December 31, 1993.

SETTING:

A regional poison center certified by the American Association of Poison Control Centers.

PATIENTS:

Seventy-six patients treated with the oral N-acetylcysteine solution by the intravenous route.

INTERVENTIONS:

None.

MEASUREMENTS AND MAIN RESULTS:

We report the indications and adverse events associated with the intravenous administration of the oral N-acetylcysteine preparation. Four (4/76, 5.3%) patients developed adverse events attributable to N-acetylcysteine. None of these events involved hemodynamic, cardiovascular, or pulmonary effects. All reactions occurred during infusion of the initial N-acetylcysteine dose. There were three (3/76, 3.9%) deaths overall; however, they were not attributable to the intravenous administration of the oral N-acetylcysteine preparation.

CONCLUSIONS:

Intravenous administration of the oral N-acetylcysteine preparation appears to have limited adverse effects and offers another mechanism of delivery of the potentially lifesaving N-acetylcysteine when oral administration is not possible.

PMID:
9428541
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wolters Kluwer
    Loading ...
    Support Center